Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Multi-centre, Evaluator-blinded, Split-hand, no Treatment-controlled Study to Evaluate the Safety and Efficacy of Restylane Vital for Skin Rejuvenation of the Dorsal Hands in Chinese Subjects

NCT02545608 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT02545608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02545608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Multi-centre, Evaluator-blinded, Split-hand, no Treatment-controlled Study to Evaluate the Safety and Efficacy of Restylane Vital for Skin Rejuvenation of the Dorsal Hands in Chinese Subjects
Lead sponsor
Galderma R&D
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2015
Completion date
March 15, 2017
Enrollment
109 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dorsal hands